Arhaus Inc
NASDAQ:ARHS
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
7.06
12.98
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one
ARHS
stock under the Base Case scenario is
9.39
USD.
Compared to the current market price of 10.74 USD,
Arhaus Inc
is
Overvalued by 13%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Arhaus Inc.
| US |
|
Williams-Sonoma Inc
NYSE:WSM
|
|
| JP |
|
Nitori Holdings Co Ltd
TSE:9843
|
|
| ZA |
L
|
Lewis Group Ltd
JSE:LEW
|
|
| MT |
H
|
HomeChoice International PLC
JSE:HIL
|
|
| UK |
|
Dunelm Group PLC
LSE:DNLM
|
|
| US |
|
RH
NYSE:RH
|
|
| CA |
|
Leon's Furniture Ltd
TSX:LNF
|
|
| AU |
|
Nick Scali Ltd
ASX:NCK
|
|
| CN |
|
Chengdu Fusen Noble-House Industrial Co Ltd
SZSE:002818
|
|
| CA |
|
Sleep Country Canada Holdings Inc
TSX:ZZZ
|
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Revenue & Expenses Breakdown
Arhaus Inc
Balance Sheet Decomposition
Arhaus Inc
| Current Assets | 626.2m |
| Cash & Short-Term Investments | 262.2m |
| Receivables | 1.1m |
| Other Current Assets | 362.9m |
| Non-Current Assets | 752.5m |
| PP&E | 728.8m |
| Intangibles | 11m |
| Other Non-Current Assets | 12.7m |
| Current Liabilities | 466.2m |
| Accounts Payable | 69.5m |
| Accrued Liabilities | 142m |
| Other Current Liabilities | 254.7m |
| Non-Current Liabilities | 512.1m |
| Long-Term Debt | 52.6m |
| Other Non-Current Liabilities | 459.5m |
Free Cash Flow Analysis
Arhaus Inc
| USD | |
| Free Cash Flow | USD |
Earnings Waterfall
Arhaus Inc
|
Revenue
|
1.4B
USD
|
|
Cost of Revenue
|
-825.4m
USD
|
|
Gross Profit
|
536m
USD
|
|
Operating Expenses
|
-439.9m
USD
|
|
Operating Income
|
96.1m
USD
|
|
Other Expenses
|
-22.6m
USD
|
|
Net Income
|
73.5m
USD
|
ARHS Profitability Score
Profitability Due Diligence
Arhaus Inc's profitability score is 53/100. The higher the profitability score, the more profitable the company is.
Score
Arhaus Inc's profitability score is 53/100. The higher the profitability score, the more profitable the company is.
ARHS Solvency Score
Solvency Due Diligence
Arhaus Inc's solvency score is 74/100. The higher the solvency score, the more solvent the company is.
Score
Arhaus Inc's solvency score is 74/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
ARHS Price Targets Summary
Arhaus Inc
According to Wall Street analysts, the average 1-year price target for
ARHS
is 11.3 USD
with a low forecast of 9.09 USD and a high forecast of 14.7 USD.
Dividends
Current shareholder yield for
ARHS is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
ARHS
stock under the Base Case scenario is
9.39
USD.
Compared to the current market price of 10.74 USD,
Arhaus Inc
is
Overvalued by 13%.